Debash Marye Nigatie, Kumie Getinet, Sisay Assefa, Gedfie Solomon, Abebe Wagaw, Ashagre Agenagnew, Misganaw Tadesse, Debash Habtu, Reta Melese Abate
Department of Medical Laboratory Science, College of Health Sciences, Woldia University, P.O. box 400, Woldia, Ethiopia.
Department of Medical Laboratory Science, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
BMC Infect Dis. 2025 Jan 11;25(1):54. doi: 10.1186/s12879-025-10441-4.
Intestinal parasite infections remain a serious public health concern around the world, particularly in countries with inadequate sanitation. The study aims to ascertain the total magnitude of intestinal parasites in diabetes patients throughout the African countries.
The aim of this systematic review and meta-analysis was to determine the general burden of intestinal parasites among diabetic patients in Africa.
A systematic search was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol for studies reporting intestinal parasite infections in patients with diabetes through January 01/2000 to August13/2024. The collected data were analyzed using STATA software version 17. Seven case-control studies and nine cross-sectional studies were included in this study. Heterogeneity across studies was assessed using Cochran's Q statistic and I statistics. Subgroup analysis was carried out when the I value exceeded 50%, indicating substantial heterogeneity.
In the current systematic review and meta-analysis, the pooled prevalence of intestinal parasites in diabetic patients was 31% (95% CI: 23-38%) with heterogeneity of I = 95.94%; P < 0.001. The highest prevalence based on geographical area was in region of the Egypt 39% (95% CI: 26-52%), and based on study design was in case control studies 40% (95% CI: 28-52%). Poor hygiene and sanitation(P < 0.001), as well as diabetes mellitus status (P < 0.001), were statistically significant factors associated with patients who have diabetes.
Patients with diabetes are a high-risk group for intestinal parasitic infections and should be prioritized for screening. Therefore, it is essential to implement preventative measures for these patients.
肠道寄生虫感染仍是全球严重的公共卫生问题,尤其是在卫生设施不完善的国家。本研究旨在确定非洲各国糖尿病患者肠道寄生虫的总体感染情况。
本系统评价和荟萃分析的目的是确定非洲糖尿病患者肠道寄生虫的总体负担。
按照系统评价和荟萃分析的首选报告项目(PRISMA)协议进行系统检索,以查找2000年1月1日至2024年8月13日期间报告糖尿病患者肠道寄生虫感染的研究。使用STATA 17软件对收集的数据进行分析。本研究纳入了7项病例对照研究和9项横断面研究。使用Cochran's Q统计量和I统计量评估研究间的异质性。当I值超过50%时进行亚组分析,表明存在实质性异质性。
在当前的系统评价和荟萃分析中,糖尿病患者肠道寄生虫的合并患病率为31%(95%CI:23-38%),异质性I=95.94%;P<0.001。按地理区域划分,患病率最高的是埃及地区,为39%(95%CI:26-52%),按研究设计划分,病例对照研究中的患病率最高,为40%(95%CI:28-52%)。卫生条件差(P<0.001)以及糖尿病状态(P<0.001)是与糖尿病患者相关的统计学显著因素。
糖尿病患者是肠道寄生虫感染的高危人群,应优先进行筛查。因此,对这些患者实施预防措施至关重要。